The global recombinant vaccine market has shown substantial growth in recent years, reflecting its pivotal role in the modern healthcare landscape. As of 2023, this market reached a valuation of USD 14.91 billion, a testament to the increasing reliance on cutting-edge biotechnological methods in vaccine development. Projections for the market suggest a robust growth trajectory, with an...